PLURISTEM THERAPEUTICS INC (PSTI) Stock Income Statement
NASDAQ:PSTI - Nasdaq - US72940R3003 - Common Stock - Currency: USD
| TTM (2022-3-31) | 2021 (2021-6-30) | 2020 (2020-6-30) | 2019 (2019-6-30) | 2018 (2018-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 230.00K | 0.00 | 20.00K | 50.00K | 50.00K | |||
| Cost Of Goods | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Gross Profit | N/A | 0.00 | 20.00K | 50.00K | 50.00K | |||
| Operating Expenses | 47.53M | 50.62M | 29.50M | 35.59M | 33.78M | |||
| Research and Development | 27.71M | 13.47M | 21.64M | 28.04M | 24.48M | |||
| Selling, General, and Administrative Expenses | 20.03M | 20.56M | 7.92M | 9.16M | 11.19M | |||
| Operating Income | 47.29M | 50.62M | -29.48M | -35.53M | -33.73M | |||
| Interest Income/Expense | N/A | 781.00K | 360.00K | 110.00K | 8.54M | |||
| Other Income/Expense | N/A | 20.00K | -30.00K | 120.00K | -940.00K | |||
| Income Before Taxes | 46.86M | 49.87M | -29.15M | -35.31M | -26.13M | |||
| Net Income | 46.86M | 49.87M | -29.15M | -35.31M | -26.13M | |||
| EBITDA | 48.55M | 51.99M | -27.91M | -33.57M | -31.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.47 | 1.77 | -1.60 | -28.71 | -2.47 | |||
| Non GAAP EPS | -1.47 | -1.76 | -1.60 | -3.03 | -2.60 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 100.00% | 100.00% | 100.00% | |||
| Profit Margin | 20373.91% | N/A | -145750.00% | -70620.00% | -52260.00% | |||
| Operating Profit Margin | 20560.87% | N/A | -147400.00% | -71060.00% | -67460.00% | |||
All data in USD